From the Institute, the Biotechnology and Pharmaceutical Law Review (BPLR), formally known as the Journal of Biotechnology and Pharmaceutical Law, emerged. As one of the only legal reviews of its kind in the nation and the newest law review at NCCU School of Law, the Biotechnology and Pharmaceutical Law Review occupies a unique place within the law school community. Its goal is to expose and transform these research areas through scholarly work that analyzes and critiques newly developed issues in this realm. The Biotechnology and Pharmaceutical Law Review seeks to publish a professional periodical devoted to these areas that is useful to judges, practitioners, teachers, legislators, students, and other interested parties.
In the spring of 2008, the Biotechnology and Pharmaceutical Law Review successfully published its first issue, and it remains an annual publication. Generally, an issue consists of a collection of articles, notes, comments, and hot topics. Additionally, once a year, the Biotechnology and Pharmaceutical Law Review hosts a symposium devoted to a single legal problem or issue in the related research areas.